Misonix Reports Fourth Quarter and Fiscal Year 2021 Financial Results
02. September 2021 16:01 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix Reports Fiscal 2021 Third Quarter Financial Results
06. Mai 2021 16:01 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., May 06, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix Receives Health Canada Approval for neXus
04. März 2021 09:25 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., March 04, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix Reports Record Quarterly Revenue of $19.7 Million for Fiscal 2020 Second Quarter
05. Februar 2020 16:05 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Misonix Reports Preliminary Fiscal 2020 Second Quarter Revenue of Approximately $19.7 Million
13. Januar 2020 08:05 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
Credicorp Capital sells the majority of the Banco Santander Chile’s participation in Nexus
14. Oktober 2019 17:00 ET
|
Banco Santander Chile
SANTIAGO, Chile, Oct. 14, 2019 (GLOBE NEWSWIRE) -- We have the pleasure of communicating that the process of sale of a large portion of Banco Santander Chile’s portion in Nexus- an auxiliary...
Misonix Reports Fourth Quarter and Fiscal Year 2019 Results
14. August 2019 16:05 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...
Misonix Announces CE Mark Approval for Nexus
12. August 2019 11:20 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...
Sonatype’s Nexus User Conference to Bring 2,000 DevSecOps Leaders Together for Free, Live Streamed Event
10. Juni 2019 10:16 ET
|
Sonatype
FULTON, MD, June 10, 2019 (GLOBE NEWSWIRE) -- Sonatype, the inventors of software supply chain automation, will host its second annual Nexus User Conference on June 12, 2019. The free, live, and...
Misonix Reports Fiscal 2019 Third Quarter Revenue of $9.6 Million
08. Mai 2019 16:05 ET
|
MISONIX, Inc.
FARMINGDALE, N.Y., May 08, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...